France· FR:68886446
SALBUTAMOL VIATRIS 5 mg/2,5 ml, solution pour inhalation par nébuliseur en récipient unidose
A medicinal product containing sulfate de salbutamol, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE SALBUTAMOL
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093656646060 récipient(s) unidose(s) polyéthylène de 2,5 mlEUR 14.47
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate de salbutamol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsSalamol Steri-Neb 5 mg/2,5 ml, verneveloplossingTeva Nederland B.V.
- SwedenAiromir 2 mg/ml Lösning för nebulisatorTeva Sweden AB
- IrelandBrodilaten 5.0 mg/2.5 ml Nebuliser solutionNoridem Enterprises Limited
- FinlandVentolineGlaxoSmithKline Oy
- NorwayVentolineGlaxoSmithKline AS
- PolandVentolinGlaxoSmithKline Trading Services Limited
- BelgiumSalbutamol Teva Pharma 5 mg/2,5 mlTeva Pharma
- United StatesAlbuterolProficient Rx LP
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Novolizer Salbutamol Meda, Salbutamol Glenmark
- Belgium · Airomir, Airomir Autohaler
- Bulgaria · Buto-Asma, Вентолин
- Cyprus · Brodilaten Noridem Enterprises, Medolin
- Czechia · Buventol Easyhaler, Ecosal Inhaler
- Germany · Apsomol N Für Erwachsene Und Kinder Ab 4 Jahren, Bronchospray Autohaler
- Denmark · Airomir, Airsalb
- Estonia · Buventol Easyhaler, Ventolin
- Spain · Aldobronquial, Salbuair
- Finland · Airomir, Airomir Autohaler
- United Kingdom (Northern Ireland) · Airomir Inhaler, Airsalb
- Greece · Aerolin, Asthmotrat
- Croatia · Antamenys, Salbutamol Pliva
- Hungary · Buventol Easyhaler, Ventolin Evohaler
- Ireland · Brodilaten, Salamol
- Iceland · Salbutamol Neutec, Ventoline
- Italy · Broncovaleas, Salbutamol Noridem
- Lithuania · Salbutamol Inteli, Ventolin
- Luxembourg · Airomir, Airomir Autohaler
- Latvia · Salbutamol Inteli, Ventolin
- Malta · Ventoaldo, Ventolin
- Netherlands · Airomir Autohaler, Airomir Inhalator
- Norway · Airomir, Airomir Autohaler
- Poland · Aspulmo, Buventol Easyhaler
- Portugal · Salbutamol Gp, Salbutamol Noridem
- Romania · Salbutamol, Salbutamol Eipico
- Sweden · Airomir, Airomir Autohaler
- Slovenia · Antamenys, Ventolin
- Slovakia · Salbutamol Noridem, Ventolin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcf91668-ff50-425f-abde-6d4ce252efb3 GET /v1/drugs/bcf91668-ff50-425f-abde-6d4ce252efb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68886446",
"date_amm": "2000-05-11",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE DE SALBUTAMOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate de salbutamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.